Pembrolizumab(early breast cancer): Solution concentrate for I.V. infusion 100 mg in 4 mL vial; Keytruda® Page last updated: 14 July 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.1MB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 503KB)